MedTrace Logo

The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)

NCT03725839 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2020-02-28

No results posted yet for this study

Summary

This investigation is designed to evaluate the performance as well as the patients overall acceptance of the interface.

Conditions

Interventions

DEVICE

F&P Interface

F\&P Interface to be used for OSA therapy

Sponsors & Collaborators

  • Fisher and Paykel Healthcare

    lead INDUSTRY

Principal Investigators

  • Bhavi Ogra · Clinical Manager

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-05
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03725839 on ClinicalTrials.gov